These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4135302)

  • 1. [Tumor-immunologic phenomena: theoretic principles, clinical importance].
    Gallmeier WM
    Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:298-9. PubMed ID: 4135302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy of neoplasms. Part I - Assumptions (author's transl)].
    Szmigiel Z; Skotnicki AB
    Przegl Lek; 1975; 32(5):460-5. PubMed ID: 50612
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carcino-fetal antigens and tumor-immunotherapy].
    Renner H
    Fortschr Med; 1974 Feb; 92(5):175-8. PubMed ID: 4132198
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities of chemical modification of membraneous proteins of tumor cells considering immunological aspects (author's transl)].
    Krüger W
    Arch Geschwulstforsch; 1973; 42(1):58-72. PubMed ID: 4128625
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of skin reactive intestinal cancer antigen to the carcinoembryonic antigen of Gold and other antigens.
    Herberman RB; Hollinshead AC; von Kleist S
    Ann Immunol (Paris); 1973 Nov; 124(4):597-8. PubMed ID: 4134476
    [No Abstract]   [Full Text] [Related]  

  • 6. [Solubilisation of the carcinoembryonic antigen (CEA) from a plasma membrane fraction isolated from the cancerous human gastric mucosa (author's transl)].
    Bara J; von Kleist S; Burtin P
    Ann Immunol (Paris); 1974 Nov; 125(6):939-46. PubMed ID: 4466446
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor immunology].
    Cerni CM
    Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of CEA (carcinoembryonic antigen) level determination in patients with malignant tumours (author's transl)].
    Kimlová I; Matĕjková E
    Cas Lek Cesk; 1976 Nov; 115(45):1397-8. PubMed ID: 1000549
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunology of cancer: basic experiments and clinical progress (author's transl)].
    Pasternak G
    Arch Geschwulstforsch; 1973; 42(4):345-57. PubMed ID: 4138903
    [No Abstract]   [Full Text] [Related]  

  • 10. [Limits and possibilities of neoplasm immunotherapy].
    Kurth R
    Naturwissenschaften; 1978 Apr; 65(4):180-7. PubMed ID: 78457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response and cancer. A guide.
    Gilbert HA; Kagan AR
    Radiol Clin Biol; 1974; 43(5):409-44. PubMed ID: 4605271
    [No Abstract]   [Full Text] [Related]  

  • 12. Basic principles of the immune response and the immunologic inhibition of tumors.
    Vorlaender KO
    Allergol Immunopathol (Madr); 1973 Jul; 1(4):235-46. PubMed ID: 4794103
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical aspects of the study of neoplastic antigens].
    Lisiewicz J; Moszczyński P
    Pol Tyg Lek; 1984 Feb; 39(6):201-4. PubMed ID: 6204325
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunology of tumors.
    Burk MW; Mckhann CF
    Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunity and cancer.
    Barg S; Levin M; Rezzonico R
    Int Adv Surg Oncol; 1981; 4():337-47. PubMed ID: 7251176
    [No Abstract]   [Full Text] [Related]  

  • 17. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunodiagnostics of malignant tumours (author's transl)].
    Bubeník J
    Cas Lek Cesk; 1974; 113(12):358-60. PubMed ID: 4132894
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible significance of immune recognition of preneoplastic and neoplastic cell surfaces.
    Lappé MA
    Natl Cancer Inst Monogr; 1972 Dec; 35():49-55. PubMed ID: 4659057
    [No Abstract]   [Full Text] [Related]  

  • 20. Consideration and implications of tumor antigenic expression.
    Dodson M; Menon M
    Surg Gynecol Obstet; 1979 Nov; 149(5):770-9. PubMed ID: 388701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.